Jonas Martzloff

473 total citations
5 papers, 44 citations indexed

About

Jonas Martzloff is a scholar working on Infectious Diseases, Pharmacology and Nephrology. According to data from OpenAlex, Jonas Martzloff has authored 5 papers receiving a total of 44 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 2 papers in Pharmacology and 1 paper in Nephrology. Recurrent topics in Jonas Martzloff's work include SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (3 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Jonas Martzloff is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (3 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Jonas Martzloff collaborates with scholars based in France. Jonas Martzloff's co-authors include Gabriela Gautier-Vargas, Nicolas Keller, Laura Braun-Parvez, Françoise Heibel, Peggy Perrin, Noëlle Cognard, Sophie Caillard, Samira Fafi‐Kremer, Iliès Benotmane and Bruno Moulin and has published in prestigious journals such as Transplantation, American Journal of Transplantation and Antibiotics.

In The Last Decade

Jonas Martzloff

5 papers receiving 43 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonas Martzloff France 3 37 7 7 6 5 5 44
Constantin J. Thieme Germany 4 23 0.6× 6 0.9× 10 1.4× 4 0.7× 2 0.4× 9 33
Andrea Morrison-Porter United States 2 31 0.8× 2 0.3× 6 0.9× 4 0.7× 2 0.4× 2 38
Susan Olaf Lindvig Denmark 5 51 1.4× 1 0.1× 5 0.7× 8 1.3× 9 1.8× 6 56
Aprajita Mattoo United States 3 13 0.4× 9 1.3× 15 2.1× 6 1.0× 4 0.8× 6 32
María Castillo de la Osa Spain 3 24 0.6× 7 1.0× 8 1.3× 3 0.6× 3 32
Camille Petit-Hoang France 4 11 0.3× 5 0.7× 6 0.9× 14 2.3× 12 2.4× 11 39
Kevin Collins United States 5 42 1.1× 2 0.3× 3 0.4× 6 1.0× 7 64
Delphine Kemlin Belgium 3 20 0.5× 2 0.3× 5 0.7× 2 0.3× 3 0.6× 5 23
Ana Belkin Israel 5 39 1.1× 3 0.4× 5 0.8× 4 0.8× 11 58
Madison Ellis United States 4 50 1.4× 5 0.7× 8 1.3× 5 1.0× 6 50

Countries citing papers authored by Jonas Martzloff

Since Specialization
Citations

This map shows the geographic impact of Jonas Martzloff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas Martzloff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas Martzloff more than expected).

Fields of papers citing papers by Jonas Martzloff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonas Martzloff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas Martzloff. The network helps show where Jonas Martzloff may publish in the future.

Co-authorship network of co-authors of Jonas Martzloff

This figure shows the co-authorship network connecting the top 25 collaborators of Jonas Martzloff. A scholar is included among the top collaborators of Jonas Martzloff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonas Martzloff. Jonas Martzloff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Benotmane, Iliès, Jérôme Olagne, Gabriela Gautier-Vargas, et al.. (2023). Tixagevimab-cilgavimab as an Early Treatment for COVID-19 in Kidney Transplant Recipients. Transplantation. 107(8). e215–e218. 2 indexed citations
2.
Hannedouche, Thierry, Cécile Couchoud, François Chantrel, et al.. (2022). Diabetic kidney disease versus non‐diabetic kidney disease in type 2 diabetic patients on dialysis: An observational cohort. Endocrinology Diabetes & Metabolism. 5(4). e00281–e00281. 2 indexed citations
3.
Benotmane, Iliès, Aurélie Velay, Gabriela Gautier-Vargas, et al.. (2022). Breakthrough COVID-19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipients. American Journal of Transplantation. 22(11). 2675–2681. 35 indexed citations
4.
Ruch, Yvon, et al.. (2022). High Incidence of Acute Kidney Injury in Patients Treated with High-Dose Amoxicillin and Cloxacillin Combination Therapy. Antibiotics. 11(6). 770–770. 1 indexed citations
5.
Benotmane, Iliès, Gabriela Gautier-Vargas, Noëlle Cognard, et al.. (2022). Prediction of Vaccine Response and Development of a Personalized Anti-SARS-CoV-2 Vaccination Strategy in Kidney Transplant Recipients: Results from a Large Single-Center Study. Journal of Personalized Medicine. 12(7). 1107–1107. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026